Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Nowak

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Pharmacological Reports : PR|December 31, 2005
Zinc and depression. An updateGabriel Nowak, Bernadeta Szewczyk, Andrzej Pilc
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 17, 2010
The role of zinc in neurodegenerative inflammatory pathways in depressionBernadeta Szewczyk, Marta Kubera, Gabriel Nowak
Neural Plasticity|June 25, 2015
Relationship between Zinc (Zn (2+) ) and Glutamate Receptors in the Processes Underlying NeurodegenerationBartłomiej Pochwat, Gabriel Nowak, Bernadeta Szewczyk
Przeglad Lekarski|April 29, 2003
[Postpartum depression]Dominika Dudek, Marcin Siwek, Andrzej Zieba, et al.
Pharmacology & Therapeutics|March 22, 2021
GPCR oligomerization as a target for antidepressants: Focus on GPR39Katarzyna Mlyniec, Dominika Siodłak, Urszula Doboszewska, et al.
Journal of Affective Disorders|December 10, 2014
GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?Katarzyna Młyniec, Nicolas Singewald, Birgitte Holst, et al.
Expert Opinion on Investigational Drugs|November 2, 2014
Pregabalin for the treatment of social anxiety disorderPaweł Kawalec, Agnieszka Cierniak, Andrzej Pilc, et al.
British Journal of Pharmacology|July 17, 2020
Targeting zinc metalloenzymes in coronavirus disease 2019Urszula Doboszewska, Piotr Wlaź, Gabriel Nowak, et al.
Pharmacological Reports : PR|February 26, 2015
Ergotamine and nicergoline - facts and mythsPaweł Zajdel, Marek Bednarski, Jacek Sapa, et al.
Medycyna Pracy|October 17, 2017
[Biological significance of chromium III for the human organism]Anna Piotrowska, Wanda Pilch, Łukasz Tota, et al.
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Pharmacological Reports : PR|December 31, 2005
Zinc and depression. An updateGabriel Nowak, Bernadeta Szewczyk, Andrzej Pilc
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 17, 2010
The role of zinc in neurodegenerative inflammatory pathways in depressionBernadeta Szewczyk, Marta Kubera, Gabriel Nowak
Neural Plasticity|June 25, 2015
Relationship between Zinc (Zn (2+) ) and Glutamate Receptors in the Processes Underlying NeurodegenerationBartłomiej Pochwat, Gabriel Nowak, Bernadeta Szewczyk
Przeglad Lekarski|April 29, 2003
[Postpartum depression]Dominika Dudek, Marcin Siwek, Andrzej Zieba, et al.
Pharmacology & Therapeutics|March 22, 2021
GPCR oligomerization as a target for antidepressants: Focus on GPR39Katarzyna Mlyniec, Dominika Siodłak, Urszula Doboszewska, et al.
Journal of Affective Disorders|December 10, 2014
GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?Katarzyna Młyniec, Nicolas Singewald, Birgitte Holst, et al.
Expert Opinion on Investigational Drugs|November 2, 2014
Pregabalin for the treatment of social anxiety disorderPaweł Kawalec, Agnieszka Cierniak, Andrzej Pilc, et al.
British Journal of Pharmacology|July 17, 2020
Targeting zinc metalloenzymes in coronavirus disease 2019Urszula Doboszewska, Piotr Wlaź, Gabriel Nowak, et al.
Pharmacological Reports : PR|February 26, 2015
Ergotamine and nicergoline - facts and mythsPaweł Zajdel, Marek Bednarski, Jacek Sapa, et al.
Medycyna Pracy|October 17, 2017
[Biological significance of chromium III for the human organism]Anna Piotrowska, Wanda Pilch, Łukasz Tota, et al.
Pageof 19